Search results for "SCALES"

showing 10 items of 543 documents

The relevance of recurrent brief depression in primary care. A report from the WHO project on Psychological Problems in General Health Care conducted…

1994

This report from the WHO project on Psychological Problems in General Health Care examines the relevance in primary care of the concept of recurrent brief depression (RBD) proposed by Jules Angst. RBD refers to brief, severe depressive episodes that recur frequently, i.e. nearly once a month over, a 1-year period, according to Angst. Using a structured interview (CIDI), RBD was assessed in patients not meeting the criteria for depressive episodes lasting at least 2 weeks, as defined in the ICD-10 (DE). A substantial proportion of primary care seekers were identified as presenting RBD without other depressive disorders, 3.7% with a formal RBD diagnosis and 2.7% with frequent but not monthly …

AdultCross-Cultural ComparisonMalemedicine.medical_specialtyBipolar DisorderPsychometricsAdolescentPsychometricsPoison controlSuicide AttemptedComorbidityWorld Health OrganizationSuicide preventionOccupational safety and healthRecurrent brief depressionRecurrenceInjury preventionmedicineHumansPharmacology (medical)PsychiatryBiological PsychiatryAgedPsychiatric Status Rating ScalesDepressive DisorderPrimary Health Carebusiness.industryIncidenceGeneral MedicineMiddle Agedmedicine.diseaseCIDIComorbidityPsychiatry and Mental healthCross-Sectional StudiesFemalebusinessEuropean archives of psychiatry and clinical neuroscience
researchProduct

Emotion recognition, emotional awareness and cognitive bias in individuals with bulimia nervosa

2008

Difficulties recognizing emotion have been reported for eating disordered individuals in relation to perception of emotions in others and emotional self-awareness. It remains unclear whether this is a perceptual or cognitive-affective problem. Clarification is sought and the question of a cognitive bias is addressed when interpreting facially expressed emotions. Twenty participants with bulimia nervosa (BN) and 20 normal controls (NC) were assessed for ability to recognize emotional and neutral expressions. Emotional self-awareness was also assessed. Significant differences were found for emotional self-awareness. For emotional faces, only a poorer recognition of the emotion, surprise, for …

AdultEmotion classificationEmotionsEmotional contagionDevelopmental psychologyPerceptual DisordersArts and Humanities (miscellaneous)Surveys and QuestionnairesTask Performance and AnalysismedicineHumansExpressed emotionEmotional expressionBulimia NervosaPsychiatric Status Rating ScalesBulimia nervosaRecognition PsychologyCognitionAwarenessmedicine.diseaseControl GroupsSelf ConceptCognitive biasFacial ExpressionClinical PsychologyEating disordersPattern Recognition VisualSocial PerceptionVisual PerceptionFemaleCognition DisordersPsychologyJournal of Clinical Psychology
researchProduct

Decreased benzodiazepine receptor binding in panic disorder measured by IOMAZENIL-SPECT. A preliminary report.

1994

Single photon emission tomography (SPECT) imaging of the central benzodiazepine receptor (BZr) became possible with the newly developed ligand 123I-IOMAZENIL. The BZr binding was investigated in ten patients with panic disorder (PP) compared to ten epileptic patients (EP). Panic patients had lower IOMAZENIL uptake rates in the frontal, occipital and temporal cortex than EP indicating the involvement of the BZr complex in panic disorder.

AdultFlumazenilMalemedicine.medical_specialtymedicine.drug_classbehavioral disciplines and activitiesCerebral VentriclesInternal medicinemental disordersmedicineHumansPharmacology (medical)Biological PsychiatryBenzodiazepine receptor bindingTemporal cortexPsychiatric Status Rating ScalesTomography Emission-Computed Single-PhotonIomazenilBenzodiazepinePanic disorderPanicGeneral Medicinemedicine.diseaseReceptors GABA-AFrontal LobePsychiatry and Mental healthEndocrinologyFlumazenilAnesthesiaPanic DisorderFemaleOccipital Lobemedicine.symptomPsychologyAnxiety disordermedicine.drugEuropean archives of psychiatry and clinical neuroscience
researchProduct

Association analysis of SCN9A gene variants with borderline personality disorder

2008

Borderline personality disorder (BPD) is a serious psychiatric disorder affecting about 1-2% of the general population. Key features of BPD are emotional instability, strong impulsivity, repeated self-injurious behavior (SIB) and dissociation. In the etiology of BPD and its predominant symptoms, genetic factors have been suggested. The voltage-gated sodium channel Nav1.7 is expressed in sensory neurons and in the hippocampus, a key region of the limbic system probably dysfunctional in BPD and dissociative disorders. The alpha-subunit of Nav1.7 is encoded by the SCN9A gene on chromosome 2 and variations of SCN9A can lead to complete inability to sense pain. The aim of the present study was t…

AdultGenetic MarkersMaleOncologyCandidate genemedicine.medical_specialtyPopulationSingle-nucleotide polymorphismImpulsivityPolymorphism Single Nucleotidebehavioral disciplines and activitiesBorderline Personality DisorderInternal medicinemental disordersmedicineHumansDissociative disordersSex DistributioneducationBorderline personality disorderBiological PsychiatryGenetic associationPsychiatric Status Rating ScalesGeneticseducation.field_of_studymedicine.diseasePsychiatry and Mental healthHaplotypesCase-Control StudiesFemaleSCN9A Genemedicine.symptomPsychologyJournal of Psychiatric Research
researchProduct

Effects of immunosuppressive drugs on the cognitive functioning of renal transplant recipients: A pilot study

2011

Some renal transplant patients show cognitive, emotional, and behavioral changes as part of possible neurotoxic effects associated with immunosuppressive medication, especially tacrolimus. This study evaluated effects of immunosuppressive drugs on some cognitive tasks. Patients treated with sirolimus and cyclosporine reported some of the noncognitive side effects related to immunosuppressive treatment. We observed attention and working memory impairment in patients treated with sirolimus or tacrolimus. Performance of cyclosporine-treated subjects was similar to that of healthy volunteer controls. Since the mood, anxiety, and sleep patterns measured were unaffected, it could be concluded tha…

AdultGraft RejectionMaleSleep Wake Disordersmedicine.medical_specialtyPilot ProjectsNeuropsychological TestsDevelopmental psychologyYoung AdultSurveys and QuestionnairesInternal medicinemedicineHumansNeuropsychological assessmentCognitive deficitPsychiatric Status Rating ScalesAnalysis of Variancemedicine.diagnostic_testCognitionMiddle AgedKidney TransplantationTacrolimusTransplantationClinical Psychologysurgical procedures operativeMoodNeurologySirolimusQuality of LifeKidney Failure ChronicAnxietyFemaleNeurology (clinical)medicine.symptomCognition DisordersPsychologyImmunosuppressive AgentsFollow-Up Studiesmedicine.drugJournal of Clinical and Experimental Neuropsychology
researchProduct

Fragile-X carrier females: evidence for a distinct psychopathological phenotype?

1996

The present study examined 35 mothers (29 premutation carriers) of children with fragile-X syndrome in measures of intelligence and psychiatric disorders by comparing them with two control groups: a) 30 mothers of children in the general population and b) 17 mothers of non-fra-X retarded children with autism. Premutation carriers had a higher frequency of affective disorders than mothers from the general population. Preliminary data indicate that normally intelligent premutation carriers of the fra-X genetic abnormality have a similar frequency of affective disorders (DSM-III-R criteria [APA, 1987]) than mothers of autistic children. Neither carriers of the premutation nor carriers of the f…

AdultHeterozygotePopulationIntelligenceMothersSchizoaffective disorderTrinucleotide RepeatsReference ValuesIntellectual DisabilitymedicineHumansSchizophreniform disorderAutistic DisordereducationChildGenetics (clinical)education.field_of_studybusiness.industryWechsler ScalesMiddle Agedmedicine.diseaseFragile X syndromeSchizophreniaFragile X SyndromeMutationSchizophreniaAutismAge of onsetbusinessClinical psychologyPsychopathologyAmerican journal of medical genetics
researchProduct

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1994

Summary Side effects play a significant role in the selection of drugs to be used in panic disorder/agoraphobia whose polyphobic symptomatology often includes a suspiciousness about taking drugs and a fear of undesired side effects which may lead to the refusal of treatment. The safety, side effects and patients' acceptance of alprazolam and imipramine versus placebo were evaluated in 1168 subjects with panic disorder/agoraphobia who had been enrolled in the second phase of the Upjohn World Wide Panic Study. Side effects that worsened over baseline to a greater extent with alprazolam than with imipramine and placebo were sedation, fatigue/weakness, memory problems, ataxia and slurred speech…

AdultImipramineAdolescentSide effectPoison controlPlaceboImipramineDouble-Blind MethodmedicineHumansPharmacology (medical)Biological PsychiatryAgedPsychiatric Status Rating ScalesPharmacologyAlprazolambusiness.industryPanic disorderPanicMiddle Agedmedicine.diseasePsychiatry and Mental healthNeurologyAlprazolamAnesthesiaPanic DisorderPatient ComplianceNeurology (clinical)medicine.symptombusinessAgoraphobiamedicine.drugEuropean Neuropsychopharmacology
researchProduct

Observational Prospective Natural History of Patients with Sanfilippo Syndrome Type B

2017

To evaluate the natural course of disease progression in patients with Sanfilippo syndrome type B (mucopolysaccharidosis type IIIB), identify potential end points for future therapy trials, and characterize biomarkers related to the disease.A prospective, multicenter study was conducted. Baseline, 6-month, and 12-month assessments included neurodevelopmental status (Bayley Scales of Infant Development, Third edition), adaptive status (Vineland Adaptive Behavior Scales, Second Edition), volumetric brain magnetic resonance imaging, cerebrospinal fluid heparan sulfate, and urine glycosaminoglycan (GAG) measurements.Nineteen patients aged 1.6-31.7 years were enrolled. Over 12 months, cognition,…

AdultMale0301 basic medicinePediatricsmedicine.medical_specialtyAdolescentDiseaseBayley Scales of Infant DevelopmentMucopolysaccharidosis IIIYoung Adult03 medical and health sciences0302 clinical medicineMucopolysaccharidosis IIImedicineHumansLongitudinal StudiesProspective StudiesYoung adultChildProspective cohort studyCerebrospinal FluidGlycosaminoglycansSanfilippo syndromemedicine.diagnostic_testbusiness.industryBrainInfantMagnetic resonance imagingmedicine.diseaseMagnetic Resonance ImagingVineland Adaptive Behavior Scale030104 developmental biologyNeurodevelopmental DisordersChild PreschoolPediatrics Perinatology and Child HealthDisease ProgressionFemaleHeparitin SulfatebusinessBiomarkers030217 neurology & neurosurgeryThe Journal of Pediatrics
researchProduct

Selenium status during pregnancy: Influential factors and effects on neuropsychological development among Spanish infants

2017

Selenium(Se) has been positively associated with neurodevelopment in early life. However, its margin of safety is rather narrow, and few prospective studies have evaluated its potential neurotoxic effects at intermediate levels. We aimed to explore the association between maternal Se concentrations and child neuropsychological development, including the genetic effect modification of the Se metabolizing gene INMT. Study subjects were 650 mother-child pairs from the Spanish Childhood and Environment Project (INMA, 2003-2005). Infant neuropsychological development was assessed around 12 months of age by the Bayley Scales of Infant Development. Sociodemographic and dietary characteristics were…

AdultMale0301 basic medicinePediatricsmedicine.medical_specialtyEnvironmental EngineeringMultivariate analysisCognitiveNeurodevelopmentPhysiology010501 environmental sciences01 natural sciencesBayley Scales of Infant DevelopmentSelenium03 medical and health sciencesChild DevelopmentPregnancyGenotypeHumansEnvironmental ChemistryMedicinePrenatalProspective StudiesSelenium CompoundsProspective cohort studyWaste Management and DisposalChildren0105 earth and related environmental sciencesPsychomotor learningPregnancybusiness.industryInfantMethyltransferasesmedicine.diseasePollutionChild development030104 developmental biologyPrenatal Exposure Delayed EffectsMultivariate AnalysisTrace elementGestationFemalebusinessNutrient
researchProduct

Reductions in circulating endocannabinoid 2-arachidonoylglycerol levels in healthy human subjects exposed to chronic stressors

2016

Increasing evidence indicates that chronic stress, such as social isolation, plays an important role in the development of a variety of psychiatric and somatic disorders. Meanwhile, chronic stress imposed by prolonged isolation and confinement in the spacecraft is also one of the major concerns for the health of future interplanetary space travelers. Preclinical studies suggest that the peripheral endocannabinoid (eCB) system is involved in the regulation of the stress response and eCB signaling is implicated in the pathogenesis of stress-related diseases. However, there are only few human studies addressing this topic, of which most focusing on patients who have already developed a certain…

AdultMale0301 basic medicinemedicine.medical_specialty2-ArachidonoylglycerolArachidonic AcidsGlyceridesPathogenesis03 medical and health scienceschemistry.chemical_compoundCatecholamines0302 clinical medicineTandem Mass SpectrometrymedicineHumansChronic stressSocial isolationPsychiatryChromatography High Pressure LiquidBiological PsychiatryPsychiatric Status Rating ScalesPharmacologyStressorBrainElectroencephalographyAnandamideEndocannabinoid systemHealthy Volunteers030104 developmental biologychemistryLinear ModelsCatecholamineFemalemedicine.symptomPsychologyNeuroscienceStress Psychological030217 neurology & neurosurgeryEndocannabinoidsmedicine.drugProgress in Neuro-Psychopharmacology and Biological Psychiatry
researchProduct